BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 11576356)

  • 21. Polymorphism of the aldosterone synthase gene is not associated with progression of diabetic nephropathy, but associated with hypertension in type 2 diabetic patients.
    Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR
    Nephrology (Carlton); 2008 Dec; 13(6):492-9. PubMed ID: 18771471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The association between polymorphism of endothelial nitric oxide synthase gene and diabetic nephropathy].
    Li C; Dong Y; Lü W
    Zhonghua Nei Ke Za Zhi; 2001 Nov; 40(11):729-32. PubMed ID: 11930675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
    Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
    J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients.
    Nomiyama T; Tanaka Y; Piao L; Nagasaka K; Sakai K; Ogihara T; Nakajima K; Watada H; Kawamori R
    J Hum Genet; 2003; 48(3):138-41. PubMed ID: 12624725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Collagenase-1 (-1607 1G/2G), Gelatinase-A (-1306 C/T), Stromelysin-1 (-1171 5A/6A) functional promoter polymorphisms in risk prediction of type 2 diabetic nephropathy.
    Gantala SR; Kondapalli MS; Kummari R; Padala C; Tupurani MA; Kupsal K; Galimudi RK; Gundapaneni KK; Puranam K; Shyamala N; Guditi S; Rapur R; Hanumanth SR
    Gene; 2018 Oct; 673():22-31. PubMed ID: 29883760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of LMNA 1908C/T polymorphism with cerebral vascular disease and diabetic nephropathy in Japanese men with type 2 diabetes.
    Liang H; Murase Y; Katuta Y; Asano A; Kobayashi J; Mabuchi H
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):317-22. PubMed ID: 16117820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldose reductase gene polymorphisms and susceptibility to microvascular complications in Type 2 diabetes.
    Sivenius K; Niskanen L; Voutilainen-Kaunisto R; Laakso M; Uusitupa M
    Diabet Med; 2004 Dec; 21(12):1325-33. PubMed ID: 15569136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy.
    Shah VO; Scavini M; Nikolic J; Sun Y; Vai S; Griffith JK; Dorin RI; Stidley C; Yacoub M; Vander Jagt DL; Eaton RP; Zager PG
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2886-91. PubMed ID: 9709964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients.
    Park HC; Choi SR; Kim BS; Lee TH; Kang BS; Choi KH; Lee HY; Han DS; Ha SK
    Yonsei Med J; 2005 Dec; 46(6):779-87. PubMed ID: 16385653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes.
    Caramori ML; Canani LH; Costa LA; Gross JL
    Diabetes; 2003 Dec; 52(12):3010-3. PubMed ID: 14633865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further evidence for the association of MMP9 with nephropathy in type 2 diabetes and application of DNA pooling technology to candidate gene screening.
    Nair S; Phillips AO; Norton N; Spurlock G; Williams HJ; Craig KJ; Williams JD; Williams NM; Bowen T
    J Nephrol; 2008; 21(3):400-5. PubMed ID: 18587729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Kodama D; Saito M; Matsumoto W; Sabouri AH; Izumo S; Arimura K; Usuku K; Bangham CR; Osame M
    J Neuroimmunol; 2004 Nov; 156(1-2):188-94. PubMed ID: 15465610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease.
    Drzewoski J; Sliwińska A; Przybyłowska K; Sliwiński T; Kasznicki J; Zurawska-Klis M; Kosmalski M; Majsterek I
    Kardiol Pol; 2008 Oct; 66(10):1042-8; discussion 1049. PubMed ID: 19006025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphism in the 5'-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes.
    Heesom AE; Hibberd ML; Millward A; Demaine AG
    Diabetes; 1997 Feb; 46(2):287-91. PubMed ID: 9000706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients.
    Lajer M; Tarnow L; Fleckner J; Hansen BV; Edwards DG; Parving HH; Boel E
    Diabet Med; 2004 Aug; 21(8):867-73. PubMed ID: 15270790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study Group.
    Schmidt S; Giessel R; Bergis KH; Strojek K; Grzeszczak W; Ganten D; Ritz E
    Nephrol Dial Transplant; 1996 Sep; 11(9):1755-61. PubMed ID: 8918618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy.
    Möllsten A; Marklund SL; Wessman M; Svensson M; Forsblom C; Parkkonen M; Brismar K; Groop PH; Dahlquist G
    Diabetes; 2007 Jan; 56(1):265-9. PubMed ID: 17192491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-6 polymorphism (-634C/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes.
    Kitamura A; Hasegawa G; Obayashi H; Kamiuchi K; Ishii M; Yano M; Tanaka T; Yamaguchi M; Shigeta H; Ogata M; Nakamura N; Yoshikawa T
    Diabet Med; 2002 Dec; 19(12):1000-5. PubMed ID: 12647840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes.
    Morris BJ; Markus A; Glenn CL; Adams DJ; Colagiuri S; Wang L
    J Mol Med (Berl); 2002 Feb; 80(2):96-104. PubMed ID: 11907646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased frequency of G-protein beta 3-subunit 825 T allele in dialyzed patients with type 2 diabetes.
    Blüthner M; Schmidt S; Siffert W; Knigge H; Nawroth P; Ritz E
    Kidney Int; 1999 Apr; 55(4):1247-50. PubMed ID: 10200987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.